# Clinical Cohort Study of DHA in Neurodevelopmental Disorders

> **NCT05841927** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital of Fudan University** · enrollment: 40 (estimated)

## Conditions studied

- Autism or Autistic Traits

## Interventions

- **DIETARY_SUPPLEMENT:** Docosahexaenoic acid supplement
- **DIETARY_SUPPLEMENT:** ASD placebo

## Key facts

- **NCT ID:** NCT05841927
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05841927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05841927, "Clinical Cohort Study of DHA in Neurodevelopmental Disorders". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05841927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*